Indoco Remedies Limited has informed the Exchange regarding Change in Auditors of the company.
INDOCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indoco Remedies' board, at its meeting on 22nd May 2025, approved the re-appointment of M/s A. Y. Sathe & Co as Secretarial Auditor for a 5-year term (April 2025 to March 2030). It also appointed M/s Suresh Surana & Associates LLP as Internal Auditors for FY2025-26. Additionally, two Independent Directors — Dr. Vasudha Kamat and Mr. Abhijit Gore — were re-appointed for a second 5-year term each, effective September and October 2025 respectively. All appointments are subject to shareholder approval at the upcoming AGM. The filing clarifies the headline was about auditor changes; the detailed letter also covers independent director re-appointments. No directors resigned and no statutory auditor was changed.
This is a routine corporate governance update with no negative implications. Continuity of auditors and independent directors signals board stability, though shareholders will need to approve these re-appointments at the AGM. Likely no material impact on the stock price.